Sector: Pharmaceuticals & Biotechnology

Small Cap

Bafna Pharma Share Price

Bafna Pharmaceuticals Ltd.

₹137.70

2.67(1.98%)

Trade Now

25th May 2026 | 10:28 AM

NSE : BAFNAPH

Open Free Demat Account

Bafna Pharma Performance

Price Movement

₹137.70

₹136.10

₹140.80

↘ Today's Low↗ Today's High

1 Year Performance

₹137.70

₹72.01

₹202.06

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹140.80

Low₹136.10

Open at₹139.00

Prev Close₹135.03

Volumes952

Avg Price₹139.21

Lower Circuit₹128.28

Upper Circuit₹141.78

Historical Performance

3M High₹147.95

3M Low₹94.77

1 Yr High₹202.06

1 Yr Low₹72.01

3 Yr High₹202.06

3 Yr Low₹69.00

5 Yr High₹202.06

5 Yr Low₹69.00

Bafna Pharma Fundamentals

Market Cap

Below industry Median

327.30 Cr.

PE Ratio (TTM)

Above industry Median

33.90

Dividend Yield

Net Profit TTM

124.6% incr over last year

9.66

Net Profit Growth

124.6% incr over last year

9.66

PEG Ratio

Above industry Median

0.30

ROE

46% decr over last year

4.89

Operating Revenue TTM

147.44

Operating Revenue Growth

1% decr over last year

Book Value

Above industry Median

3.50

MFI

MFI Overbought

74.51

RSI

RSI is mid-range

54.54

EPS (TTM)

-15.52

Debt to Equity

-0.71

Face Value

Operating Profit Margin Qtr.

2.86

Operating Profit Qtr.

4.24

Net Profit Qtr.

0.32

Operating Revenue Qtr.

13.13

PB Ratio

3.50

Bafna Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	38.29	35.47	34.62	39.06	33.19
Operating Expense	35.24	31.19	29.56	35.95	30.13
Operating Profit	3.05	4.28	5.07	3.11	3.06
Depreciation	1.57	1.47	1.37	0.22	1.66
Interest	0.86	0.86	0.91	0.82	0.64
Tax	0	0	0	0	0
Net Profit	1.84	3.12	3.39	1.31	0.95

Bafna Pharma Technicals

Bafna Pharmaceuticals Ltd. EMA & SMA

₹137.70

3.01 (2.23%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹135.1

Day EMA10 ₹134.7

Day EMA12 ₹134.5

Day EMA20 ₹133.2

Day EMA26 ₹132

Day EMA50 ₹128.8

Day EMA100 ₹127.7

Day EMA200 ₹123.2

Bafna Pharma Support and Resistance

Resistance

First Resistance₹137.44

Second Resistance₹140.20

Third Resistance₹142.39

Support

First Support₹132.49

Second Support₹130.30

Third Support₹127.54

Technical Indicators

Day RSI54.54

Day MFI74.51

Day ADX19.01

Day Commodity Channel Index36.60

William-55.11

Day MACD2.51

Day MACD Signal Line3.02

Day ATR6.81

Day ROC125-27.14

Day ROC21-3.41

Bafna Pharma Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	88.3	75	75	75	75	75
FII	0	8.5	9.3	9.3	9.3	9.3
DII	0	0	0	0	0	0
Public	11.7	16.5	15.7	15.7	15.7	15.7

Bafna Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.07 K	1.21 K	88.65%
Week	2.25 K	2.27 K	98.79%
1 Month	2.7 K	2.71 K	99.76%
6 Month	4.16 K	4.62 K	90.05%

Bafna Pharma SWOT Analysis

Strengths14

Weakness5

Opportunity0

Threats0

Positive Breakout First Resistance ( LTP > R1)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Strong Momentum: Price above short, medium and long term moving averages

Mid-range Performer (DVM)

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

PEG lower than Industry PEG

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Bafna Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
19 Sep, 2013	0.6	FINAL		Equity Share

Bafna Pharma Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Medistep Healthcare Ltd.
Price (₹)	₹494.20	₹6.50	₹118	₹132.50	₹13.78	₹18
% Change	1.54%	-0.61%	-4.84%	1.85%	-0.93%	-1.37%
Revenue TTM (₹ Cr)	-	₹83.60	-	₹287.68	-	-
Net Profit TTM (₹ Cr)	-	₹-34.95	-	₹14.88	-	-
PE TTM	-	-1.50	16.20	33.00	-	6.20
1 Year Return	22.61	551	-4.69	0.28	46.26	-58.14
ROCE	28.91	-5.63	-	-	-	-

Similar Stocks

INFLUX

Influx Healthtech Ltd.

₹ 243.00

-2.72%

MEDIORG

Medicamen Organics Ltd.

₹ 24.80

+1.43%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 559.75

+0.46%

INNOVACAP

Innova Captab Ltd.

₹ 842.05

-0.74%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 77.00

+0.16%

SIGACHI

Sigachi Industries Ltd.

₹ 20.42

+0.34%

WINDLAS

Windlas Biotech Ltd.

₹ 773.05

-2.14%

VINEETLAB

Vineet Laboratories Ltd.

₹ 35.00

-1.69%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 555.65

+1.38%

ZIMLAB

Zim Laboratories Ltd.

₹ 102.50

+2.34%

MEDICO

Medico Remedies Ltd.

₹ 47.95

+0.23%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 200.00

+2.37%

LASA

Lasa Supergenerics Ltd.

₹ 8.09

+1.25%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 381.15

+1.60%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 305.00

-0.18%

ORTINGLOBE

Ortin Global Ltd.

₹ 15.05

-3.53%

BROOKS

Brooks Laboratories Ltd.

₹ 56.41

+4.99%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2275.90

-0.78%

ALPA

Alpa Laboratories Ltd.

₹ 69.15

-0.01%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 365.00

-4.31%

NECLIFE

Nectar Lifesciences Ltd.

₹ 12.39

+2.74%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 29.73

+1.09%

INDOCO

Indoco Remedies Ltd.

₹ 198.53

-0.28%

FAQ's on BAFNAPH

What is the current share price of Bafna Pharmaceuticals Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Bafna Pharmaceuticals Ltd. is ₹ 137.7 on the NSE and ₹ 136.3 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Bafna Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Bafna Pharmaceuticals Ltd. is approximately ₹ 327.3 Cr.

What are the PE and PB ratios for Bafna Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Bafna Pharmaceuticals Ltd. is 33.9, and the Price-to-Book (PB) ratio is 3.5.

What is the 52-Week High and Low for Bafna Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Bafna Pharmaceuticals Ltd. shares was ₹ 202.06, and the lowest price was ₹ 72.01.

Who are the major shareholders of Bafna Pharmaceuticals Ltd.?

Significant shareholdings in Bafna Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Bafna Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Bafna Pharmaceuticals Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Bafna Pharmaceuticals Ltd.?

Bafna Pharmaceuticals Ltd. last declared a FINAL dividend of ₹ 0.6 per share for the financial period ending 2013. The record date was set as 2013-09-19, and the payment was/is scheduled around 2013-09-19. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy